Chinese Medicine Treatment for Afatinib-Induced Paronychia

Research output: Contribution to journalArticle

Abstract

Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.

Original languageEnglish
Pages (from-to)7327359
JournalCase Reports in Oncological Medicine
Volume2017
DOIs
Publication statusPublished - 2017

Fingerprint

Paronychia
Medicine
Hedyotis
Scutellaria
Therapeutics
Epidermal Growth Factor Receptor
BIBW 2992
Neoplasms

Cite this

Chinese Medicine Treatment for Afatinib-Induced Paronychia. / Yang, Pei-Yuu; Tai, Chen-Jei.

In: Case Reports in Oncological Medicine, Vol. 2017, 2017, p. 7327359.

Research output: Contribution to journalArticle

@article{1a0cc2bdbc524f3fa5406ad36796b99d,
title = "Chinese Medicine Treatment for Afatinib-Induced Paronychia",
abstract = "Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.",
author = "Pei-Yuu Yang and Chen-Jei Tai",
year = "2017",
doi = "10.1155/2017/7327359",
language = "English",
volume = "2017",
pages = "7327359",
journal = "Case Reports in Oncological Medicine",
issn = "2090-6706",
publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Chinese Medicine Treatment for Afatinib-Induced Paronychia

AU - Yang, Pei-Yuu

AU - Tai, Chen-Jei

PY - 2017

Y1 - 2017

N2 - Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.

AB - Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.

U2 - 10.1155/2017/7327359

DO - 10.1155/2017/7327359

M3 - Article

C2 - 28948057

VL - 2017

SP - 7327359

JO - Case Reports in Oncological Medicine

JF - Case Reports in Oncological Medicine

SN - 2090-6706

ER -